Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

ARS discloses new 5alpha-reductase inhibitors

Oct. 27, 1997

ADCON-L up for advisory committee review

Oct. 24, 1997

Encouraging preliminary results for finasteride in androgenic alopecia

Oct. 23, 1997

FDA clears Dermagraft-TC for new indication

Oct. 23, 1997

FDA advisory committee to review finasteride for alopecia

Oct. 22, 1997

Zorac introduced in U.K. for psoriasis

Oct. 22, 1997

Peptech and Allergan terminate collaboration on GMDP

Oct. 20, 1997

Integra Artificial Skin receives approval in Taiwan

Oct. 16, 1997

Amarillo Biosciences licenses cytokines from Hayashibara

Oct. 14, 1997

Basic tissue regeneration patent issued to The Burnham Institute

Oct. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...